Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 5, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

Atomoxetine

Treatment given for 3 nights

DRUG

Oxybutynin

Treatment given for 3 nights

Trial Locations (1)

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER